Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
EVEROLIMUS PLUS OCTREOTIDE LAR...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
EVEROLIMUS PLUS OCTREOTIDE LAR IN PATIENTS WITH LUNG CARCINOIDS
Bibliographic Details
Main Authors:
Granberg, D
,
Fazio, N
,
Grossman, A
,
Saletan, S
,
Pannnerselvam, A
,
Wolin, E
Format:
Journal article
Published:
2014
Holdings
Description
Similar Items
Staff View
Similar Items
Effect of Everolimus plus Octreotide LAR in Patients With Advanced Lung Neuroendocrine Tumours - Analysis From RADIANT-2
by: Fazio, N, et al.
Published: (2011)
Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study.
by: Fazio, N, et al.
Published: (2013)
90Y-edotreotide for metastatic carcinoid refractory to octreotide.
by: Bushnell, D, et al.
Published: (2010)
A comparison of lanreotide and octreotide LAR for treatment of acromegaly.
by: Turner, H, et al.
Published: (1999)
Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?
by: Ramírez, C, et al.
Published: (2012)